Daily Dilution Report - Feb 10, 2026
All Events
$BURU (MC: $56M)
- New S-1: Direct Offering up to 115M shares at $0.1582. Includes 115M Pre-Funded Warrants convertible @ ~$0.0001/share (~115M potential shares).
- YA II PN, LTD: Multiple warrants potentially convertible for up to 230M shares (80M @ ~$0.01, 100M @ ~$0.25, 25M @ ~$0.375, 25M @ ~$0.47). Also $100M SEPA with 50M shares issued.
- Recent Notes/Acquisitions: H&K Note: $15M convertible @ ~$0.15/share (~99M potential shares). Orbit Acquisition: 50M shares ($8.75M value). Indigo Warrant: convertible @ ~$0.0001/share (~55.77M potential shares).
$AMTU
- Initial Public Offering (IPO) of 3M common shares at $5.00/share.
- Underwriters have an over-allotment option for up to 450K additional shares.
$EZRA (MC: $2M)
- Issuing $125K in common stock to Enquantum Ltd.
- Shares issued as consideration for increasing ownership in Enquantum Ltd.
- Price based on market value, no cash proceeds received.
$DVAX (MC: $1.8B)
- Convertible Notes
- Type of instrument: 2.50% Convertible Senior Notes due 2026
- Principal amount: $40,200,000
- Maturity: 2026
- Conversion mechanism: At and after the Effective Time, the right to convert each $1,000 principal amount of 2026 Notes was changed into a right to convert into an amount of cash equal to the Conversion Rate in effect on the relevant Conversion Date multiplied by $15.50 (the Offer Price). The unit of Reference Property is $15.50 cash.
- Type of instrument: 2.00% Convertible Senior Notes due 2030
- Principal amount: $225,000,000
- Maturity: 2030
- Conversion mechanism: At and after the Effective Time, the right to convert each $1,000 principal amount of 2030 Notes was changed into a right to convert into an amount of cash equal to the Conversion Rate in effect on the relevant Conversion Date multiplied by $15.50 (the Offer Price). The unit of Reference Property is $15.50 cash.
- Stock Compensation Plans
- Type of instrument: Company's 2011 Equity Incentive Plan
- Action: Terminated in connection with the Merger.
- (+33 more items; see filing)
$VAL (MC: $5.6B)
- Valaris Warrants convert into Transocean shares as part of merger.
- Valaris Restricted Stock Units (RSUs) vest and convert to Transocean shares.
- Valaris Performance Stock Units (PSUs) vest and convert to Transocean shares.
$IPW (MC: $5M)
- $2M Series A Senior Secured Convertible Note issued.
- Convertible note issued at 6% original issue discount.
- Conversion into common stock will increase outstanding shares.
$TSN (MC: $23.3B)
- 70M Class B Common shares convertible 1:1 into Class A Common Stock.
- Class B shares carry 10x voting rights and dividend restrictions.
$ERNA (MC: $2M)
- Direct Offering of 19M shares + 2M Pre-Funded Warrants (~2M potential shares @ $0.01/share exercise), package price $0.50.
- 21M Common Warrants issued with offering (~21M potential shares @ $0.68/share exercise).
- Past: ~$28.4M Convertible Notes converted to ~1.89M shares @ ~$15.00/share.
$CUZ (MC: $4.3B)
- While the accompanying base prospectus (filed on May 8, 2024) describes various types of securities that Cousins Properties Incorporated and Cousins Properties LP *may* offer from time to time under a "shelf" registration statement (including common stock, warrants, preferred stock, and depositary shares), this particular prospectus supplement does not detail any active or immediately planned issuance of common stock or instruments convertible into common stock, nor does it quantify any active stock compensation plans.
- Specifically:
- The Capitalization table on page S-15 shows:
- Common stock authorized: 300,000,000 shares
- Common stock issued and outstanding: 167,981,990 shares (actual and pro forma as adjusted)
- Preferred stock authorized: 20,000,000 shares
- Preferred stock outstanding: none (actual and as adjusted)
- The "DESCRIPTION OF WARRANTS" section on page 15 states: "We may issue warrants for the purchase of common stock. The warrants may be issued independently or together with any other securities offered by any prospectus supplement. ... The applicable prospectus supplement will describe the terms of the warrants..." This indicates that no warrants are being offered or described in this filing.
- The "DESCRIPTION OF PREFERRED STOCK" section on page 23 notes that the board has authority to issue 20,000,000 shares of preferred stock, inclusive of 7,335,000 shares designated as "limited voting preferred stock". However, it explicitly states: "As of May 8, 2024, there were no shares of our limited voting preferred stock issued and outstanding." (page 24). It also clarifies that specific terms for any *future* preferred stock offering would be in an applicable prospectus supplement.
- There is no mention of convertible notes or convertible preferred stock being offered or outstanding.
- There is no description of an ATM (At-the-Market) Program, Equity Line / ELOC, Direct Offering / Registered Direct, or PIPE Deal with specific amounts or terms in this filing.
- The document does not detail any Stock Compensation Plans with specific reserved shares or other dilutive impacts.
- (+2 more items; see filing)
$FOUR (MC: $5.2B)
- Private placement of 423,296 Mandatory Convertible Preferred Stock to an insider.
- Part of $191.8M Simplification Transactions.
$ATCH (MC: $4M)
- Issuing common stock for Commercial Bancorp acquisition.
- Exact shares unknown, contingent on seller elections, valued at ~$0.23/share.
$HI (MC: $2.3B)
- Company Notes Repurchases (Indicates potential for future issuance or cash-out impacting outstanding shares)
- Type of instrument: Change of Control Offers for Company Notes
- Dollar amounts repurchased (Company 2029 Notes): $361,792,000
- Dollar amounts repurchased (Company 2031 Notes): $330,591,000
- Key terms: Repurchased pursuant to Change of Control Offers, expired February 9, 2026.
- Merger Consideration for Common Stock (Represents the conversion of existing equity into cash)
- Type of instrument: Merger Consideration for Common Stock
- Dollar amounts: $32.00 per share
- Key terms: Each share of Company Common Stock converted into $32.00 in cash.
- Merger Consideration for Equity Awards (Represents the cash-out of options and restricted stock units)
- Type of instrument: Company Options
- Key terms: Vested and cashed out based on Merger Consideration, less applicable per share exercise price. Options with exercise price equal to or greater than Merger Consideration were canceled for no consideration.
- (+27 more items; see filing)
$RIG (MC: $5.2B)
- Acquiring Valaris, issuing new RIG shares; Valaris shareholders to own ~47% of combined company.
- Valaris warrants, RSUs & PSUs to convert into RIG stock/warrants, potential future dilution.
$DC (MC: $746M)
- Direct Offering: 12.34M common shares @ $6.08/share, raising $75M.
- Underwriters' overallotment option for 1.85M common shares @ $6.08/share.
$FPS (MC: $7.7B)
- IPO Offering: 16.59M Class A shares @ $27/share from company, plus 2.49M shares via underwriters' option.
- Overallotment: 8.4M Class A shares purchased by underwriters.
- Equity Lines: Up to 73.58M Class A shares for Opco LLC interest redemptions.
$PUMP (MC: $1.2B)
- This filing does not contain any stock dilution events. The document details an amendment to a Master Loan and Security Agreement, which involves an increase in borrowing capacity and the issuance of new debt instruments (promissory notes). This is debt financing and does not directly dilute existing shareholders' equity by issuing new shares.
- NONE
$EWCZ (MC: $222M)
- This filing describes a proposed merger transaction where European Wax Center, Inc. ($EWCZ) will be acquired. This transaction itself is a significant event for shareholders as it results in the cancellation of existing shares and the receipt of cash. However, the question asks for *stock dilution events*, which typically refer to the issuance of new shares or securities that could increase the total number of outstanding shares and thus dilute the ownership percentage of existing shareholders.
- Therefore, based on the specific request to extract *dilution events* in the form of new issuances (warrants, convertible notes, ATM programs, etc.), and not the consummation of a merger that cancels existing equity, the following applies:
- NONE
$XIFR (MC: $957M)
- The filing primarily concerns amendments to a senior secured revolving credit facility. While a credit facility is a financial obligation, its amendment, as described, does not directly result in the issuance of new equity or instruments that would immediately dilute existing shareholders' ownership.
- Therefore, the output is:
- NONE
$CLRS
- IPO: Primary offering of 23.8M Class A shares @ $40-$44/share, plus 3.57M underwriters' option.
- Post-IPO, 112.6M Class B shares convertible 1:1 to Class A. 100.15M Class A shares converted from preferred stock pre-IPO.
- Significant future dilution: 35.17M shares reserved for 2026 Incentive Plan, 5.28M for ESPP, and up to 33.37M potential shares from Global Corp. options.
$GOOGL (MC: $3923.3B)
- These notes are explicitly described as debt and do not contain any provisions for conversion into equity (common stock or preferred stock). The filing does not mention any warrants being offered, nor does it specify any current at-the-market (ATM) programs, equity lines, direct offerings of equity, or PIPE deals for equity as part of this transaction. While the accompanying base prospectus discusses the *potential* to issue preferred stock with conversion rights or warrants to purchase common stock from its shelf registration, this specific prospectus supplement (the 424B5) does not detail any *current issuance* of such dilutive instruments. It also does not present any new stock compensation plans or shares reserved as part of this specific offering.
- Therefore, this SEC filing does not describe any stock dilution events.
- NONE
$OSCR (MC: $3.2B)
- The filing details a secured three-year revolving credit facility of $475,000,000 with an expansion option of up to an additional $100,000,000. This is a debt facility, not an issuance of equity or instruments that directly dilute existing shareholders by creating new shares. While it increases the Company's liabilities and could impact future financial performance, it does not represent a stock dilution event in itself.
$VNRX (MC: $25M)
- 2026 Lind Note: $2.4M principal convertible @ ~$0.5714/share (~10M potential shares).
- 2026 Lind Warrant: Up to 7.000M shares @ ~$0.5714 exercise.
- PIPE: Lind Global Asset Management XII LLC involved in recent $2.4M note and warrant issuance.
$WRAP (MC: $92M)
- February 2026 Private Placement:
- Type of instrument: Common Shares
- Number of shares: 1,700,000 shares
- Key terms: Issued pursuant to a Purchase Agreement dated February 2, 2026, for resale by Selling Securityholders.
- Type of instrument: Common Warrants
- Number of shares underlying: 2,500,000 shares
- Exercise price: $2.30 per share
- Expiration: Five years from the date of issuance
- Key terms: Issued pursuant to a Purchase Agreement dated February 2, 2026, with accompanying Common Shares or Pre-Funded Warrants.
- Type of instrument: Pre-Funded Warrants
- Number of shares underlying: 800,000 shares
- Exercise price: $0.0001 per share
- (+43 more items; see filing)
$MOVE (MC: $10M)
- Committed Equity Facility (ChEF): Up to $1B from Chardan for common stock sales with VWAP discounts; registers 110M shares for resale.
- Merger Impact: 15.22M Corvex common, 17.03M Corvex preferred, and 4.73M Corvex warrants converting into MOVE common shares.
- Merger Earnout: Up to 10M shares contingent on $15/$25 VWAP targets post-merger.
$NGTF (MC: $6M)
- Equity Line: $25M agreement with Mast Hill Fund for future common stock sales.
- Convertible Notes: Issued $3.445M in recent senior secured notes, convertible @ ~$0.033/share or market price.
- Preferred Stock: Series C issued for services/acquisitions (e.g., 94,250 Series C = 565.5M common @ 6000:1).
- Warrants: Mast Hill warrant for 6M shares @ $0.10 exercise.
$BRTX (MC: $9M)
- Unit Offering: Up to 9.709M common shares/pre-funded warrants & 9.709M common stock warrants @ ~$1.03/unit.
- Series B Preferred: 1.398M shares outstanding, convertible to 1.398M common shares @ $10.00/share.
- Outstanding Warrants: 4.495M shares @ $4.91 WAE; Options: 5.252M shares @ $2.58 WAE.
$SVCO (MC: $116M)
- Direct Offering: Issued 167,281 shares @ $3.83/share as acquisition earnout.
- Stock Comp: 2.585M shares for RSUs; 3.275M shares reserved for Incentive Plan; 453,936 shares for ESPP.
- Shelf Registration: Up to $50M aggregate for various instruments (potential ATM, warrants, preferred).
$MNTS (MC: $4M)
- ATM Program: Increased total capacity to $50M for common stock sales.
$EMO (MC: $979M)
- ATM Program: Up to $323.17M (est. 6.934M shares @ ~$46.61).
- Mandatory Redeemable Preferred Stock: 2.64M shares outstanding ($92.4M liquidation value) dilutes common shareholder claims.
- DRIP: Dividend Reinvestment Plan can issue new shares under specific market conditions.
$SEGG (MC: $4M)
- New ATM Program: Up to $5.57M through Dawson James (est. 6.023M shares at ~$1.21).
- Registered Direct: 2.450M shares sold @ $0.70/share for ~$1.7M (Jan 20, 2026).
- Convertible Note: 1M shares issued from a converted note (price not provided).
$OFRM (MC: $157M)
- IPO: Issued 7.632M shares @ $18.00/share, plus underwriters' option for up to 1.650M shares.
- Stock Plans: 2026 Omnibus Incentive Plan and ESPP allow future share issuance.
$SSAC
- IPO Warrants: 8.625M shares @ $11.50 exercise.
- PIPE: Sponsor/investors purchased Private Placement Units (~279K Class A shares) & 768,529 restricted Class A shares for ~$2.8M.
- Rights: 17.25M rights (convertible to 3.45M shares at 1/5th per right).
$UPXI (MC: $66M)
- Registered Direct Offering: 6.337M common shares & warrants for ~$7.4M gross @ $1.17/unit.
- Warrants: Issued for 6.337M shares @ $1.50 exercise; amended 3.289M warrants, reducing exercise to $2.83.
- Existing ATM program noted.
$ESGH (MC: $136M)
- Converted $11,721 in Labrys Note for 2,800 shares @ $4.1859/share.
- Issued 23,131 shares as $100K contingent consideration for Moku license (80% of 5-day avg. close).
$GNLN (MC: $2M)
- This Form 8-K filing does not describe any direct stock dilution events such as the issuance of warrants, convertible notes, convertible preferred stock, ATM programs, equity lines, direct offerings, PIPE deals, or the reservation of shares for stock compensation plans.
- The filing details a material definitive agreement concerning a Token Purchase and Sale Agreement and a Token Lending Agreement with Berachain Operations Corporation. This involves the lending of stablecoins and the purchase of BERA tokens, which is a cryptocurrency, not a direct equity dilution event for Greenlane Holdings, Inc.
- Therefore, the output is:
- NONE
$SCWO (MC: $44M)
- Item 1.01 Entry into a Material Definitive Agreement:
- Type of Instrument: Amendment No. 1 to Letter Agreement with Mr. Yaacov (Kobe) Nagar.
- Key Terms: This amendment relates to the appointment of candidates to the Board of Directors. It does not directly describe the issuance of new securities that would cause dilution. However, it mentions a "Replacement Candidate" to be appointed on the one-year anniversary of the Third Candidate's appointment. The appointment of directors can sometimes be accompanied by the issuance of equity or options, but this filing does not specify such an event.
- Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers:
- Type of Instrument: Appointment of Stephen McKnight to the Board of Directors.
- Key Terms: Mr. McKnight will receive compensation for his Board service consistent with the Company’s standard compensation arrangements for non-employee directors. As of the date of filing, committee assignments for Mr. McKnight were not yet determined, but they would be reported by amendment.
- Potential Dilution Event: Mr. McKnight plans to continue efforts coordinating with management on potential financing opportunities and "may participate as an investor in one or more potential financing opportunities." The aggregate financing amount of any successful transaction is expected to exceed $120,000. Crucially, this filing does not specify the *type* of financing (e.g., equity, debt, convertible instruments), the *number of shares* to be issued, or the *price per share* for any potential financing in which Mr. McKnight might invest. Therefore, while it indicates potential future dilution, the specific terms are not provided in this document.
- NONE
$CCO (MC: $1.1B)
- This filing describes a merger agreement where Clear Channel Outdoor Holdings, Inc. will be acquired. The primary impact on existing stock is the conversion of all outstanding common stock, options, and various forms of restricted stock units into cash. This means existing shareholders will be cashed out, rather than experiencing dilution from new shares being issued at this stage.
- However, the filing details the treatment of Company Equity Awards, which implies the existence of these instruments and their conversion into cash as part of the merger. While these are not "dilution events" in the traditional sense of new shares being issued that dilute existing shareholders *prior* to the merger, they represent a mechanism by which existing equity holders' interests are settled.
- Type of instrument: Company Options
- Key terms: Cancelled and converted into the right to receive cash. The cash amount is the product of the number of shares subject to the option and the excess of the Per Share Price ($2.43) over the exercise price per share. Options with an exercise price equal to or greater than the Per Share Price are cancelled for no consideration.
- Type of instrument: Company RSUs (Restricted Stock Units)
- Key terms: Immediately vest and are cancelled and converted into the right to receive cash equal to the Per Share Price ($2.43) multiplied by the total number of shares subject to the RSU.
- Type of instrument: Company PSUs — Completed Performance
- Key terms: Immediately vest and are cancelled and converted into the right to receive cash equal to the Per Share Price ($2.43) multiplied by the total number of shares subject to the PSU (based on actual performance).
- Type of instrument: Company PSUs — Uncompleted Performance
- Key terms: Cancelled and converted into the right to receive cash. The cash amount is the product of the Per Share Price ($2.43) and the total number of shares subject to the PSU (as determined in the Merger Agreement). This cash consideration will vest and become payable based on a service-based vesting schedule, with double-trigger accelerated vesting.
- Type of instrument: Company PSUs — Company Stock Price PSUs
- Key terms: Cancelled and converted into cash. One-third of the PSU value (Per Share Price ($2.43) multiplied by one-third of the total shares subject to the PSU) is converted into immediate cash. The remaining two-thirds is converted into cash that will vest and become payable on May 31, 2028, subject to continued employment and double-trigger accelerated vesting.
- (+3 more items; see filing)
$BEAT (MC: $49M)
- Direct Offering (Feb 2025): 6.75M shares @ ~$1.70/share.
- Stock Compensation Plan: 6.01M shares available for issuance, plus 5% annual increase.
- Warrants: Multiple tranches totaling ~5.83M potential shares with varying exercise prices ($1.875 - $7.50).
$ASTI (MC: $23M)
- Multiple Warrants: Series A, B, Pre-Funded, and Placement Agent Warrants referenced.
- Multiple Convertible Preferred Stock: Series A, Z, and 1C Convertible Preferred Stock referenced.
- Direct Offerings: Securities Purchase Agreements for registered direct offerings referenced; specific share counts & prices not detailed in this filing.
$PHGE (MC: $7M)
- Convertible Preferred Stock: 3,300 Series Y Preferred ($1.65M potential shares @ $2/share) + 0.26M dividend shares.
- Warrants: 3.3M investor warrants & 99K placement agent warrants, both @ $2.50/share.
- PIPE Deal: Private placement leading to 5.21M potential shares.
$AEON (MC: $12M)
- PIPE Deal: Up to 51.29M potential shares via private placement, including pre-funded warrants (17.82M potential shares) and certain warrants (13.16M potential shares).
- Warrants: Daewoong Warrants for 8M shares @ $1.09; Settlement Warrants for 0.125M shares @ $2.
- Convertible Notes: Up to $16.5M principal from Old Notes ($15M) and a New Note ($1.5M).
$AVX (MC: $2M)
- PIPE Deal (2025): 86.69M shares @ $2.36, plus pre-funded warrants for 6.12M shares.
- Convertible Notes & Warrants (Jan 2026): $7M principal notes & warrants (4.79M potential shares) @ $2.41/share.
- Stock Compensation: 13.94M shares reserved; ~1.82M shares issued for advisors, directors, executives, & debenture conversions.
$DC (MC: $746M)
- Stock Compensation: 1.07M shares related to tax withholding for equity awards.
$FOXF (MC: $804M)
- The filing primarily concerns a cooperation agreement with Engine Capital L.P., which involves the appointment of new directors to the Board and the formation of a committee. It does not mention any issuance of warrants, convertible notes, convertible preferred stock, ATM programs, equity lines, direct offerings, PIPE deals, or the reservation of shares for stock compensation plans.
$WAT (MC: $19.5B)
- Share Issuance: 38.54M shares issued (approx 39.2% of outstanding) for business combination.
- Equity Grants: New director received $229K in restricted stock and options.
$BDX (MC: $59.1B)
- The filing details a spin-off and merger with Waters Corporation. While this transaction involves the distribution of shares and a conversion of shares, it's a corporate restructuring of existing businesses and does not represent the issuance of new equity that would dilute existing shareholders in the traditional sense (e.g., through warrant exercises, convertible note conversions, ATM programs, etc.).
- The filing mentions:
- Distribution of SpinCo Common Stock: This is a pro-rata distribution to existing BDX shareholders, not an issuance of new equity diluting them.
- Conversion of SpinCo Common Stock into Waters Common Stock: This is a conversion based on the merger agreement, not a new issuance of equity by BDX.
- Share Repurchases: The filing states that BDX expects to use cash from the distribution for share repurchases. Share repurchases *reduce* the number of outstanding shares, thus having an anti-dilutive effect, not a dilutive one.
- Therefore, there are no instruments or programs described in this filing that would lead to stock dilution as requested.
$CION (MC: $454M)
- This filing describes the issuance of new debt, not equity. Therefore, there are no stock dilution events reported in this document.
- NONE
$TIVC (MC: $974,823)
- Equity Line of Credit (ELOC): Up to $50M, sales at 95-97% of VWAP, capped at 506,848 shares initially.
- Warrants issued as commitment fee: 437,012 shares @ $0.0001/share.
$GOLD (MC: $1.6B)
- PIPE Deal: $150M at $44.50/share (3.37M shares).
- 11.9% discount to 10-day VWAP.
$GBIO (MC: $36M)
- Here's an analysis of the provided SEC filing for Generation Bio Co. ($GBIO) to extract stock dilution events.
- Analysis of Dilution Events:
- Let's go through the categories requested:
- Warrants: No mention of outstanding warrants or the issuance of new warrants in this filing.
- Convertible Notes: No mention of convertible notes in this filing.
- Convertible Preferred Stock: No mention of convertible preferred stock in this filing.
- ATM (At-the-Market) Programs: The filing mentions the termination of a Sales Agreement for an "at-the-market" offering program. This indicates that any *potential* future dilution from this program was halted. There is no mention of any past or ongoing ATM offerings that resulted in dilution up to the date of this filing.
- Type of instrument: ATM (At-the-Market) Programs
- Key terms: Sales Agreement with TD Securities (USA) LLC terminated effective February 9, 2026. This is a termination of a potential dilution mechanism, not an event of dilution itself within this report.
- Equity Lines / ELOC: No mention of equity lines of credit in this filing.
- Direct Offerings / Registered Direct: No mention of direct offerings or registered direct offerings in this filing.
- PIPE Deals: No mention of PIPE deals in this filing.
- (+10 more items; see filing)
$PLBY (MC: $198M)
- The closest event is the sale of equity interests in a joint venture entity:
- Type of instrument: Sale of Equity in a Joint Venture (Playboy China (BVI) Limited)
- Dollar amounts: $45,000,000 (total purchase price for 50% equity)
- Share counts: The filing refers to the issuance and sale of "class B ordinary shares of the Company" to UTG. It details the number of shares changing hands in tranches:
- Initial Closing: 1,333 Class B ordinary shares issued by the Company to UTG, and 334 Class B ordinary shares sold by PLBY to UTG.
- Second Closing: 1,667 Class B ordinary shares sold by PLBY to UTG.
- Third Closing: 1,666 Class B ordinary shares sold by PLBY to UTG.
- *Note: The filing does not provide a direct conversion ratio or total number of shares outstanding to determine the dilution impact on PLBY common stock. It refers to "equity interest" and "class B ordinary shares" of a subsidiary, not common stock of the parent company PLBY being offered to the public.*
- Prices per share: The pricing is described in aggregate amounts for tranches of shares. For the Initial Closing, the consideration for 1,333 shares to be issued by the Company to UTG is $11,997,000, implying a price of approximately $9,000 per share. For the 334 Class B Shares sold by PLBY to UTG, the consideration is $3,006,000, also implying a price of approximately $9,000 per share. The subsequent closings also imply similar per-share pricing based on aggregate amounts and share counts.
- Key terms:
- Counterparty: UTG Brands Management Group Limited
- Transaction: Sale and issuance of 50% equity in Playboy China (BVI) Limited.
- (+9 more items; see filing)
$LIMN (MC: $39M)
- Warrants settled for 4M common shares to Clear Street LLC.
- Issued to resolve legal judgment of $7.5M+.